Maximus Inc. (MMS) CEO Sells $1,425,000.00 in Stock
Maximus Inc. (NYSE:MMS) CEO Richard A. Montoni sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, November 25th. The stock was sold at an average price of $57.00, for a total value of $1,425,000.00. Following the transaction, the chief executive officer now directly owns 641,114 shares in the company, valued at $36,543,498. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Shares of Maximus Inc. (NYSE:MMS) opened at 57.33 on Friday. The stock has a market capitalization of $3.77 billion, a price-to-earnings ratio of 21.31 and a beta of 1.15. The stock’s 50 day moving average price is $53.77 and its 200 day moving average price is $56.30. Maximus Inc. has a 12 month low of $43.69 and a 12 month high of $61.68.
Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, November 10th. The company reported $0.77 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.72 by $0.05. Maximus had a return on equity of 24.93% and a net margin of 7.42%. The company had revenue of $623.10 million for the quarter, compared to analyst estimates of $610.65 million. During the same period in the previous year, the company posted $0.53 earnings per share. The firm’s revenue was up 7.7% on a year-over-year basis. Analysts expect that Maximus Inc. will post $3.00 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 30th. Investors of record on Tuesday, November 15th will be given a dividend of $0.045 per share. The ex-dividend date of this dividend is Thursday, November 10th. This represents a $0.18 annualized dividend and a dividend yield of 0.31%. Maximus’s dividend payout ratio is presently 6.67%.
Several large investors have recently added to or reduced their stakes in the stock. D.A. Davidson & CO. raised its stake in Maximus by 4.6% in the third quarter. D.A. Davidson & CO. now owns 79,470 shares of the company’s stock valued at $4,491,000 after buying an additional 3,463 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in Maximus by 3.2% in the third quarter. Price T Rowe Associates Inc. MD now owns 759,798 shares of the company’s stock valued at $42,974,000 after buying an additional 23,698 shares in the last quarter. Sawtooth Solutions LLC raised its stake in Maximus by 14.0% in the third quarter. Sawtooth Solutions LLC now owns 6,246 shares of the company’s stock valued at $353,000 after buying an additional 766 shares in the last quarter. Credit Suisse AG raised its stake in Maximus by 0.8% in the third quarter. Credit Suisse AG now owns 187,719 shares of the company’s stock valued at $10,618,000 after buying an additional 1,417 shares in the last quarter. Finally, Ameritas Investment Partners Inc. raised its stake in Maximus by 65.2% in the third quarter. Ameritas Investment Partners Inc. now owns 25,346 shares of the company’s stock valued at $1,434,000 after buying an additional 10,000 shares in the last quarter. Institutional investors own 99.72% of the company’s stock.
A number of brokerages have recently weighed in on MMS. Zacks Investment Research lowered Maximus from a “hold” rating to a “sell” rating in a research report on Saturday, November 12th. Jefferies Group reissued a “buy” rating and issued a $65.00 price target (down from $67.00) on shares of Maximus in a research report on Wednesday, November 16th. Maxim Group increased their price target on Maximus from $71.00 to $74.00 and gave the company a “buy” rating in a research report on Thursday, August 4th. Sidoti lowered Maximus from a “buy” rating to a “neutral” rating and set a $55.00 price target for the company. in a research report on Tuesday, November 15th. Finally, Raymond James Financial Inc. lowered Maximus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 9th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $61.89.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs.
Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.